Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
12.39
+0.17 (1.39%)
At close: Sep 8, 2026, 4:00 PM EDT
12.50
+0.28 (2.29%)
Pre-market: Sep 9, 2026, 8:07 AM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $905.22 million as of September 8, 2026. Its market cap has increased by 469.95% in one year.
Market Cap
905.22M
Enterprise Value
738.85M
1-Year Change
469.95%
Ranking
Category
Stock Price
$12.39
ChartMarket Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $905.22M, an increase of 893.70%. That is a compound annual growth rate of 48.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 905.22M | 121.75% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 964.13M |
| Olema Pharmaceuticals | 961.16M |
| Design Therapeutics | 953.12M |
| Immix Biopharma | 947.90M |
| Ardelyx | 939.44M |
| Climb Bio | 913.24M |
| Aclaris Therapeutics | 892.03M |
| Theravance Biopharma | 885.73M |